Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer

Lung Cancer

Volumn 70, Issue 2, 2010, Pages 195-199

  Funakoshi, Yasunobu ^a   Maeda, Hajime ^a   Takeda, Shin ichi ^a   Nojiri, Takashi ^a   Kawamura, Tomohiro ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Computed tomography; Nodal involvement; Prognosis; Squamous cell carcinoma; Surgery; Upstaging

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77957016581     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.02.010     Document Type: Article

References (18)

1. Silvestri G.A., Gould M.K., Margolis M.L., Tanoue L.T., McCrory D., Toloza E., et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines. Chest 2007, 132:178S-201S. [2nd ed.].
2. Fritscher-Ravens A., Bohuslavizki K.H., Brandt L., Bobrowski C., Lund C., Knofel W.T., et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003, 123:442-451.
3. Gould M.K., Kuschner W.G., Rydzak C.E., Maclean C.C., Demas A.N., Shigemitsu H., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003, 139:879-892.
4. The American Thoracic Society and the European Respiratory Society Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997, 156:320-322.
5. Asamura H., Nakayama H., Kondo H., Tsuchiya R., Shimosato Y., Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?. J Thorac Cardiovasc Surg 1996, 111:1125-1134.
6. Aronchick J.M. CT of mediastinal lymph nodes in patients with non-small cell lung carcinoma. Radiol Clin North Am 1990, 28:5735-5781.
7. International Union Against Cancer (UICC). TNM classification of malignant tumors 1997, John Wiley & Sons, Inc., New York. 5th ed. L.H. Sobin, Wittekind Ch (Eds.).
8. Lopez-Encuentra A., Garcia-Lujan R., Rivas J.J., Rodriguez-Rodriguez J., Torres-Lanza J., Varela-Simo G Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 2005, 79:974-979.
9. Gdeedo A., Van Schil P., Corthouts B., Van Mieghem F., Van Meerbeeck J., Van Marck E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 1997, 12:224-227.
10. Fernando H.C., Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990, 65:2503-2506.
11. D'Cunha J., Herndon J.E., Herzan D.L., Patterson G.A., Kohman L.J., Harpole D.H., et al. Cancer and Leukemia Group B. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 2005, 48:241-246.
12. Yamazaki K., Yoshino I., Yohena T., Kameyama T., Tagawa T., Kawano D., et al. Clinically predictive factors of pathologic upstaging in patients with peripherally located clinical stage IA non-small cell lung cancer. Lung Cancer 2007, 55:365-369.
13. Suzuki K., Nagai K., Yoshida J., Nishimura M., Nishiwaki Y. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 2001, 72:352-356.
14. Ketchedjian A., Daly B.D., Fernando H.C., Florin L., Hunter C.J., Morelli D.M., et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2006, 132:544-548.
15. Takamochi K., Nagai K., Suzuki K., Yoshida J., Ohde Y., Nishiwaki Y. Clinical predictors of N2 disease in non-small cell lung cancer. Chest 2000, 117:1577-1582.
16. Andre F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., Brichon P.Y., et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000, 18:2981-2989.
17. Robinson L.A., Ruckdeschel J.C., Wagner H., Stevens CW American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines. Chest 2007, 132:243S-265S. [2nd ed.].
18. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., Nishiwaki Y. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 1999, 118:145-153.